glp-1 analog drugs A Comprehensive Review of the Role of Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Product Sample collection:Walk-in clinic Cigna will stop covering

glp-1 analog drugs A Comprehensive Review of the Role of Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Product Sample collection:Walk-in clinic Cigna will stop covering

Cigna will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its ​employee health plan effective July 1, according to Reuters.

doi: 10.1210/en.2011-1443 [DOI] [PMC free article] [PubMed] [Google Scholar] 33

Product

Sample collection:Walk-in clinic

The higher new patient starts may be attributed to patients’ motivation to treat sleep apnea as recent weight loss may spur more engagement and focus on other health conditions